Georgetown University

This study looks at whether people with HPV-positive throat cancer who have had surgery can safely receive a lower dose of radiation to a smaller area (just the neck, not the original tumor site). The goal is to keep cancer from coming back while reducing side effects. About 30 a…

This study tests whether adding two immunotherapy drugs (durvalumab and tremelimumab) to standard chemotherapy is safe and effective for people with HIV who have stage IV non-small cell lung cancer. About 18 participants will receive the treatment and be monitored for side effect…

This study tests whether a telehealth program can help cancer survivors prevent mouth sores, gum disease, and tooth decay, and improve their quality of life. Researchers will enroll 100 cancer survivors who finished primary treatment at least 6 months ago. Participants will eithe…

This study tests whether azeliragon can reduce heart damage caused by chemotherapy in women with early-stage breast cancer. About 48 participants will receive azeliragon alongside standard chemo to see if it is safe and protects the heart. The goal is to lower the risk of heart p…

This early-phase study tests the safety of combining two drugs, NEROFE and doxorubicin, in people with advanced solid tumors that have a KRAS mutation and express ST2. The main goal is to find the best dose and schedule. About 24 participants will receive weekly infusions of both…

This study tests whether a decision-support tool helps high-risk Black and Latina women make informed choices about getting a breast MRI. About 80 women will either receive standard care or extra guidance to help them decide. The goal is to see if the tool improves knowledge and …